Open original FDA record ↗Recall record
- FDA identifier
- Z-3112-2017
- Company in FDA record
- Qualigen Inc
- FDA record creation date
- Sep 7, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Specific lots have been reported to produce falsely lower than expected results for Vitamin D
Source facts
- Action
- The firm, Qualigen, sent an "URGENT: PRODUCT RECALL" letter dated 7/5/2017 to its customers by email or fax on 07/07/2017. The letter described the product, problem and actions to be taken. The customers were instructed to stop using the products immediately; discard any product remaining in your inventory; and complete, sign and return the attached CONFORMATION OF NOTIFICATION form by email to: babugan@qualigeninc.com or nsomera@qualigenic.com or fax to: 760-918-9127 by 7/15/2017. Please contact System Support at 877-709-2169, Option #2 if you need further assistance.
- Initiated
- 2017-07-07
- Root cause
- Under Investigation by firm
- Terminated
- 2018-10-22
- Distribution
- Worldwide Distribution: US (Nationwide) and to countries of: Germany, Switzerland, turkey and UAE.
- Recall number
- Z-3112-2017
- Recall status
- Terminated
- CDRH record ID
- 157763
- FDA record created
- 2017-09-07
- Recall event number
- 77726